Bactrim DS Suspension Dosing for 14.7 kg Child
For a child weighing 14.7 kg, administer Bactrim suspension (200-40 mg/5 mL) at 15 mL (600 mg sulfamethoxazole/120 mg trimethoprim) every 12 hours for most common infections.
Dosing Calculation
The standard pediatric dosing for Bactrim is 40 mg/kg/day of sulfamethoxazole and 8 mg/kg/day of trimethoprim, divided into two doses every 12 hours 1. This is the FDA-approved dosing for urinary tract infections, acute otitis media, and shigellosis in children over 2 months of age.
For a 14.7 kg child:
- Sulfamethoxazole: 40 mg/kg/day × 14.7 kg = 588 mg/day (294 mg per dose)
- Trimethoprim: 8 mg/kg/day × 14.7 kg = 117.6 mg/day (58.8 mg per dose)
Since the suspension contains 200 mg sulfamethoxazole and 40 mg trimethoprim per 5 mL:
- 15 mL every 12 hours provides 600 mg sulfamethoxazole and 120 mg trimethoprim per dose
- This delivers approximately 41 mg/kg/day sulfamethoxazole and 8.2 mg/kg/day trimethoprim
Context-Specific Dosing
For Skin/Soft Tissue Infections (including MRSA)
The same dosing applies: 8-12 mg/kg/day of trimethoprim component in 2 divided doses 2, 3, 2. For this child, 15 mL twice daily falls within this range and is appropriate.
For Pneumocystis jirovecii Pneumonia (Treatment)
Much higher doses are required: 75-100 mg/kg/day sulfamethoxazole and 15-20 mg/kg/day trimethoprim in 4 divided doses 1. This would require 27.5-37.5 mL every 6 hours, which is substantially higher than standard dosing.
For PCP Prophylaxis
Lower doses suffice: 150 mg/m²/day sulfamethoxazole with 30 mg/m²/day trimethoprim in 2 divided doses 4. For a child of this weight, this typically translates to approximately 10 mL twice daily.
Important Caveats
Age restriction: Bactrim is contraindicated in children under 2 months of age due to risk of kernicterus 5, 1
Duration: Standard treatment courses are typically 10-14 days for UTIs, 5 days for shigellosis and traveler's diarrhea, and 7 days for skin infections depending on clinical response 1
Renal function: Dose reduction is required if creatinine clearance is below 30 mL/min 1
Resistance concerns: Recent pharmacovigilance data shows TMP-SMX use is associated with increased resistance in bacteremia isolates (RR 2.91-3.35) 6, 7, though this must be balanced against efficacy for specific indications
Adverse effects: Monitor for rash (2.5-fold increased risk vs other antibiotics), hyperkalemia (56-fold increase vs azithromycin), and hematologic abnormalities including pancytopenia 7
The 15 mL twice daily dosing provides adequate exposure matching adult therapeutic levels and achieves pharmacodynamic targets for organisms with MIC ≤0.5 mg/L 8. For organisms with higher MICs (up to 1 mg/L), doses of 12-15 mg/kg/day of trimethoprim component may be needed 8.